|
1
|
Wild S, Roglic G, Green A, et al: Global
prevalence of diabetes: estimates for the year 2000 and projections
for 2030. Diabetes care. 27:1047–1053. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
van Dieren S, Beulens JW, van der Schouw
YT, Grobbee DE and Neal B: The global burden of diabetes and its
complications: An emerging pandemic. Eur J Cardiovasc Prev Rehabil.
17 (Suppl 1):S3–S8. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gæde P, Vedel P, Larsen N, Jensen GV,
Parving HH and Pedersen O: Multifactorial intervention and
cardiovascular disease in patients with type 2 diabetes. N Engl J
Med. 348:383–393. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Colhoun HM, Betteridge DJ, Durrington PN,
Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI,
Charlton-Menys V and Fuller JH; CARDS investigators, : Primary
prevention of cardiovascular disease with atorvastatin in type 2
diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS):
Multicentre randomised placebo-controlled trial. Lancet.
364:685–696. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ruan Y, Lin N, Ma Q, Chen R, Zhang Z, Wen
W, Chen H and Sun J: Circulating LncRNAs analysis in patients with
type 2 diabetes reveals novel genes influencing glucose metabolism
and Islet β-cell function. Cell Physiol Biochem. 46:335–350. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–869. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu JY, Yao J, Li XM, Song YC, Wang XQ, Li
YJ, Yan B and Jiang Q: Pathogenic role of lncRNA-MALAT1 in
endothelial cell dysfunction in diabetes mellitus. Cell Death Dis.
5:e15062014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li X, Wang H, Yao B, Xu W, Chen J and Zhou
X: lncRNA H19/miR-675 axis regulates cardiomyocyte apoptosis by
targeting VDAC1 in diabetic cardiomyopathy. Sci Rep. 6:363402016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang S, Xu H, Zou L, Xie J, Wu H, Wu B, Yi
Z, Lv Q, Zhang X, Ying M, et al: LncRNA uc.48+ is involved in
diabetic neuropathic pain mediated by the P2X3 receptor in the
dorsal root ganglia. Purinergic Signal. 12:139–148. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan R, Wang K, Peng R, Wang S, Cao J, Wang
P and Song C: Genetic variants in lncRNA SRA and risk of breast
cancer. Oncotarget. 7:22486–22496. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen G, Yu D, Nian X, Liu J, Koenig RJ, Xu
B and Sheng L: LncRNA SRA promotes hepatic steatosis through
repressing the expression of adipose triglyceride lipase (ATGL).
Sci Rep. 6:355312016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Long J, Zhu N, Zhang CJ, Liu C, Tuo QH,
Liao DF and Qin L: LncRNA-SRA promotes vascular smooth muscle cells
proliferation via MEK/ERK/CREB signaling pathway. Atheroscler
Suppl. 32:113–121. 2018. View Article : Google Scholar
|
|
13
|
Rivard A and Andrés V: Vascular smooth
muscle cell proliferation in the pathogenesis of atherosclerotic
cardiovascular diseases. Histol Histopathol. 15:557–571.
2000.PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ahlqvist E, Van Zuydam NR, Groop LC and
McCarthy MI: The genetics of diabetic complications. Nat Rev
Nephrol. 11:277–287. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun SF, Tang PMK, Feng M, Xiao J, Huang
XR, Li P, Ma RCW and Lan HY: Novel lncRNA Erbb4-IR promotes
diabetic kidney injury in db/db mice by targeting miR-29b.
Diabetes. 67:731–744. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhuo C, Jiang R, Lin X and Shao M: LncRNA
H19 inhibits autophagy by epigenetically silencing of DIRAS3 in
diabetic cardiomyopathy. Oncotarget. 8:1429–1437. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cao B, Liu N and Wang W: High glucose
prevents osteogenic differentiation of mesenchymal stem cells via
lncRNA AK028326/CXCL13 pathway. Biomed Pharmacother. 84:544–551.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gong Y, Zhu Y, Zhu B, Si X, Heng D, Tang
Y, Sun X and Lin L: LncRNA MALAT1 is up-regulated in diabetic
gastroparesis and involved in high-glucose-induced cellular
processes in human gastric smooth muscle cells. Biochem Biophys Res
Commun. 496:401–406. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Güemes M, Rahman SA and Hussain K: What is
a normal blood glucose? Arch Dis Child. 101:569–574. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brownlee M and Hirsch IB: Glycemic
variability: A hemoglobin A1c-independent risk factor for diabetic
complications. JAMA. 295:1707–1708. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liebl A, Mata M and Eschwege E: Evaluation
of risk factors for development of complications in type II
diabetes in Europe. Diabetologia. 45 (Suppl 1):S23–S28. 2002.
View Article : Google Scholar
|
